BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Cantor Fitzgerald
AstraZeneca
Julphar
Farmers Insurance
UBS
US Army
Cerilliant
Accenture

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,747,504

« Back to Dashboard

Summary for Patent: 5,747,504
Title: Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors
Abstract:The invention relates to a method of treating cardiac insufficiency by using compounds of the formula I ##STR1## in which n is 1 or 2, R, R.sup.1, R.sup.2 and R.sup.3 are identical or different and each denote hydrogen or an organic radical and R.sup.4 and R.sup.5, together with the atoms carrying them, form a mono-, bi- or tri-cyclic heterocyclic ring system. The invention furthermore relates to compounds of the formula I and agents containing these for use in the treatment of the abovementioned disease.
Inventor(s): Henning; Rainer (Hattersheim am Main, DE), Urbach; Hansjorg (Kronberg/Taunus, DE), Teetz; Volker (Hofheim am Taunus, DE), Geiger; Rolf (Frankfurt am Main, DE), Scholkens; Bernward (Kelkheim, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt am Main, DE)
Application Number:08/709,286
Patent Claim Types:
see list of patent claims
Use; Delivery;

Drugs Protected by US Patent 5,747,504

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,747,504

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany34 13 710.6Apr 12, 1984

International Patents Family Members for US Patent 5,747,504

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 585502 ➤ Subscribe
Australia 4104885 ➤ Subscribe
Canada 1246457 ➤ Subscribe
Cyprus 2163 ➤ Subscribe
Germany 3413710 ➤ Subscribe
Germany 3587675 ➤ Subscribe
Germany 3588198 ➤ Subscribe
European Patent Office 0158927 ➤ Subscribe
Austria 171376 ➤ Subscribe
Austria 98128 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Express Scripts
Chubb
McKinsey
Medtronic
Cantor Fitzgerald
Harvard Business School
Daiichi Sankyo
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot